Ductal adenocarcinoma (DAC) is the most common variant histological subtype of prostate
carcinoma and has an aggressive clinical course. DAC is usually characterized and treated …

Background Ductal prostate adenocarcinoma (DAC) is a rare, aggressive, histologic variant
of prostate cancer that is treated with conventional therapies, similar to high-risk prostate …

Prostatic acinar adenocarcinoma accounts for approximately 95% of prostate cancer (CaP)
cases. The remaining 5% of histologic subtypes of CaP are known to be more aggressive …

Introduction Studies have confirmed that parts of the non-coding genes in the human
genome play an important role in the pathogenesis and metastasis of prostate cancer …

Background Prostatic ductal adenocarcinoma (DAC) is an aggressive histologic variant of
prostate cancer that often warrants multimodal therapy and poses a significant diagnostic …

Background Ductal carcinoma of the prostate (DCP) is a rare type of prostate cancer (PCa)
with a higher degree of infiltration and worse prognosis than acinar adenocarcinoma of the …

The heterogeneity of prostate cancer is evident at clinical, morphological and molecular
levels. To aid clinical decision making, a three-tiered system for risk stratification is used to …

Please see the Editorial Comment by Jabi Shriki discussing this article. PET with targeted
radiotracers has become integral to mapping the location and burden of recurrent disease in …

Objectives Vasohibin-1 (VASH1) is an endogenous angiogenesis regulator expressed in
activated vascular endothelial cells. We previously reported that high VASH1 expression is a …

导管腺癌(ductal adenocarcinoma, DAC) 是前列腺癌最常见的组织学亚型变异,
具有侵袭性的临床病程. 由于疾病罕见, 传统的诊断方式如血清前列腺特异性抗原(prostate …